Monday 22 March 2021

Dr Malcolm Skingle CBE PhD, GSK

Conference Talk!
At our TFNetworkSpring21 conference on "Creating Value for Economies: Collaborate - Innovate - Educate"

Malcolm has BSc in Pharmacology/Biochemistry and a PhD in Neuropharmacology. He has worked in the pharmaceutical industry for over 40 years and gained a wide breadth of experience in management of research activities. Part of his former role as a research leader in a Neuropharmacology department involved co-supervising collaborations with academics in the UK, Europe and USA. He has over 60 publications including articles on the interface between industry and academia.

He coordinates Academic Liaison at GSK, managing staff in the US and UK. His role involves close liaison with several groups outside the Company for example government departments, research and funding councils, biotechnology companies and other science-driven organisations. He sits on many external bodies including the REF2021 Main Panel A, UKRI Infrastructure Advisory Committee and the BBSRC Council. He also chairs several groups including the Diamond (Synchrotron) Industrial Advisory Board, the Science Industry Partnership for apprenticeships and the ABPI strategic leadership group for Academic Collaboration, Education & Skills (ACES).

Malcolm was awarded a CBE in the 2009 Queen’s Birthday Honours in recognition of his contribution to the pharmaceutical industry as well as an Honorary Professorship from the University of Birmingham and an honorary DSc from the University of Hertfordshire. Malcolm was elected as a Fellow into the Faculty of Medicine at Imperial College London in 2011 and an honorary fellow to the British Pharmacological Society in 2020.

LinkedIn

No comments:

Post a Comment

Note: only a member of this blog may post a comment.